New

Create, analyze, optimize your ETF portfolio. Start now →

Advertisement
Advertisement

MDEVvsFTXHETF Comparison

ETF 1
MDEV

First Trust Indxx Medical Devices ETF

This fund is part of
Healthcare Technology
+1.36%
VS
ETF 2
FTXH

First Trust Nasdaq Pharmaceuticals ETF

This fund is part of
US Health Care
+1%

First Trust Indxx Medical Devices ETF (MDEV) belongs to the Healthcare Technology segment. First Trust Nasdaq Pharmaceuticals ETF (FTXH) is part of the US Health Care segment. Both ETFs have the same top 1 sector exposures: Healthcare. MDEV is more expensive with a Total Expense Ratio (TER) of 0.7%, versus 0.6% for FTXH. MDEV is down -1.75% year-to-date (YTD) with +$994K in YTD flows. FTXH performs better with 24.38% YTD performance, and +$978M in YTD flows. Run a side-by-side ETF comparison of MDEV and FTXH below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

MDEV vs FTXH performance and flow charts

Performance

-4.0-2.00.02.04.06.0%Aug 17Aug 24Aug 31Sep 8Sep 15

Cumulative Flows

0 M10 M20 M30 M40 MAug 17Aug 24Aug 31Sep 8Sep 15

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 09/16/2026
1M3MYTD1Y3Y5Y
Perf.
MDEV
FTXH
-2.73%+1.55%
+9.99%+14.60%
-1.75%+24.38%
+1.51%+48.45%
+10.26%+61.80%
-25.10%+70.31%
Flows
MDEV
FTXH
-+$33M
+$994K+$968M
+$994K+$978M
+$994K+$981M
+$767K+$973M
-$24M+$977M
Volatility and drawdown
3M1Y3Y5Y
Volatility
MDEV
FTXH
+17.31%+19.72%
+16.32%+17.55%
+16.40%+17.00%
+19.25%+16.34%
Max drawdown
MDEV
FTXH
-6.88%-5.41%
-18.07%-7.50%
-20.26%-19.32%
-41.66%-19.32%
Max drawdown duration
MDEV
FTXH
24d22d
253d99d
594d393d
1819d393d
Trading data

Create an account to view trading data

Join for free
MDEV
FTXH
Last sale
9/17/2026 at 4:55 PM
$20.47
$41.39
Previous close
09/17/2026
$20.44
$40.84
Consolidated volume
09/17/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of August 31, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

Create an account to view replication quality

Join for free
MDEV
FTXH
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 9/17/2026 at 4:55 PM
Live
Closed
MDEV
FTXH
Last price
$20.47
$41.39
1D performance
+0.16%
+1.36%
AuM$3.10 M$1.05 B
E/R0.7%0.6%
Characteristics
MDEV
FTXH
Management strategyPassivePassive
ProviderFirst TrustFirst Trust
BenchmarkIndxx Global Medical Equipment IndexNASDAQ US Smart Pharmaceuticals Index
N° of holdings4749
Asset classEquitiesEquities
Trailing 12m distribution yield
Join
Join
Inception dateJune 23, 2021September 20, 2016
ESGNoNo
Advertisement
Exposure

Countries

MDEV
USA
55.07%
Japan
8.74%
Other
36.19%
FTXH
USA
95.79%
Other
4.21%

Sectors

MDEV
Healthcare
95.98%
Other
4.02%
FTXH
Healthcare
99.86%
Other
0.14%
Advertisement

Diversification

MDEV

Total weight of top 15 holdings out of 15

37.67%
FTXH

Total weight of top 15 holdings out of 15

66.98%

Top 15 holdings

Data as of July 31, 2026
MDEV
WuXi AppTec Co., Ltd.
2.91%
Baxter International, Inc.
2.82%
Demant A/S
2.62%
DexCom, Inc.
2.57%
Olympus Corp.
2.55%
Sysmex Corp.
2.54%
Revvity, Inc.
2.53%
West Pharmaceutical Services, Inc.
2.51%
Agilent Technologies, Inc.
2.48%
Bio-Rad Laboratories, Inc.
2.46%
Merit Medical Systems, Inc.
2.42%
Sonova Holding AG
2.38%
Waters Corp.
2.31%
Thermo Fisher Scientific, Inc.
2.29%
LivaNova Plc
2.28%
FTXH
Merck & Co., Inc.
7.58%
Eli Lilly & Co.
7.43%
AbbVie, Inc.
7.11%
Johnson & Johnson
6.78%
Bristol Myers Squibb Co.
6.61%
Amgen, Inc.
3.53%
Biogen, Inc.
3.52%
Vertex Pharmaceuticals, Inc.
3.43%
Viatris, Inc.
3.40%
Regeneron Pharmaceuticals, Inc.
3.34%
Pfizer Inc.
3.17%
Cardinal Health, Inc.
3.14%
Gilead Sciences, Inc.
3.03%
Incyte Corp.
2.48%
United Therapeutics Corp.
2.43%
Frequently asked questions about MDEV and FTXH

How have the MDEV and FTXH ETFs performed in 2026?

As of September 16, 2026, MDEV is down -1.75% year-to-date (YTD), while FTXH has returned 24.38%. That puts FTXH better performer ahead so far this year.

Which ETF is attracting more investor money: MDEV or FTXH?

Year-to-date, the MDEV ETF saw +$994K in flows, compared to +$978M for FTXH.

Which ETF is more volatile: MDEV or FTXH?

Over the past year, MDEV had a volatility of 16.32%, while FTXH experienced 17.55%.

Which ETF is bigger: MDEV or FTXH?

As of September 16, 2026, MDEV holds $3.10 M in assets under management (AUM), while FTXH manages $1.05 B.

What sectors do the MDEV and FTXH ETFs invest in?

MDEV leans toward sectors like Healthcare. Meanwhile, FTXH focuses on Healthcare.

What are the top holdings of the MDEV ETF and FTXH ETF?

MDEV top holdings include WuXi AppTec Co., Ltd., Baxter International, Inc. and Demant A/S. FTXH holds in its top three: Merck & Co., Inc., Eli Lilly & Co. and AbbVie, Inc..

Which ETF is more diversified: MDEV or FTXH?

MDEV holds 47 securities with 37.67% of its assets in the top 15. FTXH has 49 securities and a top 15 weight of 66.98%.

Advertisement
Advertisement
Advertisement
ETF INVESTOR TOOLS

Build and Analyze Your ETF Portfolio Like a Pro

Create your own ETF portfolio in minutes and instantly see allocations, exposures, performance, and risk. Visualize diversification across asset classes, regions, and sectors. Stress-test ideas, compare benchmarks, and refine your strategy with professional-grade analytics.

Portfolio Builder